Completed OBSERVATIONAL NCT04508556

Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study (COVID)

Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols

Sponsor: Maastricht University

Conditions Covid19

Interventions Breath Biopsy face masks with removable filters and fitted PVA strip Nasopharyngeal swab oropharyngeal swabs

Updated 8 times since 2020 Last updated: Mar 29, 2021 Started: Sep 30, 2020 Primary completion: Dec 19, 2020 Completion: Dec 19, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Maastricht University leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
May 2021 — Dec 2021 [monthly]

Completed

Status: Not Yet Recruiting → Completed
Jan 2021 — May 2021 [monthly]

Not Yet Recruiting

▶ Show 3 earlier versions

Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting
Oct 2020 — Nov 2020 [monthly]

Not Yet Recruiting
Sep 2020 — Oct 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University
OLVG
Owlstone Ltd

Data source: Owlstone Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amsterdam, Netherlands